High Tide (HITI) Stock Overview
Engages in the cannabis retail business in Canada, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HITI from our risk checks.
HITI Community Fair Values
Create NarrativeSee what 20 others think this stock is worth. Follow their fair value or set your own to get alerts.
Top Community Narratives
The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake
Gain Therapeutics: The Under-the-Radar Biotech With Big Parkinson’s Potential Key Takeaways Gain Therapeutics (GANX) is developing GT-02287 – an oral, first-in-class, potentially disease-modifying treatment for Parkinson’s disease targeting the GCase enzyme pathway. Parkinson’s disease represents a $4 billion U.S. market with zero approved disease-modifying therapies.
Read full narrativeHigh Tide Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$2.49 |
| 52 Week High | CA$4.06 |
| 52 Week Low | CA$2.10 |
| Beta | 1.07 |
| 1 Month Change | 9.21% |
| 3 Month Change | 5.96% |
| 1 Year Change | 4.18% |
| 3 Year Change | 91.54% |
| 5 Year Change | -68.60% |
| Change since IPO | -50.34% |
Recent News & Updates
High Tide's Future Potential Will Surge with 15% Revenue Growth
Raj confirms store staff gets a commission for every new ELITE sign-up. That creates massive internal motivation – employees pitch ELITE customers.High Tide: Why The Market Is Wrong After Q4
Summary High Tide Inc. reported record Q4 earnings that the market didn't appreciate. The core Canadian Canna Cabana business continues to thrive, creating great long-term earnings potential. The European cannabis wholesale business was weak in Q4 due to transitory disruption in Portugal. Remexian's performance should recover. The ecommerce segment has continued to weaken High Tide's earnings, but speculative CBD potential after Trump's marijuana rescheduling could aid the U.S. performance. I estimate HITI stock to have 103% upside to $4.67. Read the full article on Seeking AlphaRecent updates
Shareholder Returns
| HITI | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 2.0% | -1.9% | 2.1% |
| 1Y | 4.2% | 33.3% | 30.6% |
Return vs Industry: HITI underperformed the US Pharmaceuticals industry which returned 33.4% over the past year.
Return vs Market: HITI underperformed the US Market which returned 31% over the past year.
Price Volatility
| HITI volatility | |
|---|---|
| HITI Average Weekly Movement | 5.8% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: HITI has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: HITI's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 1,832 | Raj Grover | www.hightideinc.com |
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products.
High Tide Inc. Fundamentals Summary
| HITI fundamental statistics | |
|---|---|
| Market cap | US$218.88m |
| Earnings (TTM) | -US$34.23m |
| Revenue (TTM) | US$461.31m |
Is HITI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HITI income statement (TTM) | |
|---|---|
| Revenue | CA$629.85m |
| Cost of Revenue | CA$467.36m |
| Gross Profit | CA$162.50m |
| Other Expenses | CA$209.23m |
| Earnings | -CA$46.73m |
Last Reported Earnings
Jan 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.53 |
| Gross Margin | 25.80% |
| Net Profit Margin | -7.42% |
| Debt/Equity Ratio | 58.4% |
How did HITI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/07 10:14 |
| End of Day Share Price | 2026/05/07 00:00 |
| Earnings | 2026/01/31 |
| Annual Earnings | 2025/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
High Tide Inc. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Frederico Yokota Choucair Gomes | ATB Cormark |
| David Kideckel | ATB Cormark |
| Doug Cooper | Beacon Securities Limited |